Therapeutically targeting mutations in myeloma: NF-B, t(4;14) and BRAF
As our knowledge of the genetics of multiple myeloma (MM) advances, we can more precisely understand and target the disease. Here, Martin Kaiser, MD, of the Institute of Cancer Research, London, UK, d...
Author: VJHemOnc
Added: 05/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts